Novo’s Insulin Icodec: Hypoglycemia Events In Type 1 Diabetics Put Broad Indication At Risk

 
• By Sue Sutter
Continuous glucose monitor
Novo Nordisk proposes to restrict use in type 1 diabetics to those who wear a continuous glucose monitoring device. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers